跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IDHIFA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
IDHIFA
Authorized
STANDARD
IDHIFA
celgene inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
617e4a00274271f6
Company
celgene inc
Type
Standard
Approval Details
Approval Id
617e4a00274271f6
Drug Approval Canada Name
IDHIFA
Product Name
IDHIFA
Status
Cancelled Post Market
Status Date
2023-06-30
Original Market Date
2019-02-27
Din
02485435
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01XX59 ENASIDENIB
Atc Name
l 01 xx 59
Aig Number
0161190002
Company Name
celgene inc
Company Address
300, 2344 Alfred-Nobel Boulevard, Saint-Laurent, Quebec, Canada, H4S 0A4
Active Ingredients
ENASIDENIB (ENASIDENIB MESYLATE)
100 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
617e4a00274271f6
Type
Standard
Back to Health Canada Approvals